Clinical trials recruiting for Graft Rejection
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Calcineurin inhibitor withdrawal at 6 months | 1 |
| Continue low dose calcineurin inhibitor (CNI) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Tennessee | 2 |
| Texas | 2 |
| California | 1 |
| Colorado | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| New York | 1 |
| Pennsylvania | 1 |
| South Carolina | 1 |
Top cities
Self-screener
Recruiting trials
- OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
- Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
- Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Related conditions
Trials recruiting for Graft Rejection often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Graft Rejection trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.